The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

Lignende værker

• Duration of anticoagulant treatment for unprovoked deep-vein thrombosis – is prolonged long enough?
  af: Huisman, Menno V., et al.
  Udgivet: (2019)
• Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
  af: Brown, Joshua D., et al.
  Udgivet: (2018)
• Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism
  af: van der Hulle, Tom, et al.
  Udgivet: (2015)
• Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
  af: Klok, Frederikus A., et al.
  Udgivet: (2019)
• Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
  af: Zielinski, Gilda Denise, et al.
  Udgivet: (2019)